Reliant Technologies Secures $15 Million in Venture Funding
Reliant Technologies, Inc. announced recently that it has closed a $15 million round of funding led by Delphi Ventures, a premier medical technology venture capital firm and a new investor in the company. Delphi joined with Three Arch Partners and Meritech Capital Partners, earlier venture partners, and other early round individual investors in completing this offering.
“We are very pleased to have led Reliant’s Series E financing,” said David Douglass, General Partner, Delphi Ventures. “Aesthetic laser medicine and surgery has experienced explosive growth over the past several years and Reliant Technologies has become one of the leading companies in this industry. We look forward to working with Reliant’s management team and investor group to continue to build the Company’s market leadership position.”
“We are very pleased to have completed this Eround of funding. It is a significant endorsement of our Fraxel� technology and our pursuit of growth opportunities in the rapidly evolving field of aesthetic laser medicine and surgery,” said Eric Stang, president and chief executive officer of Reliant Technologies. “These additional funds will enable us to aggressively build our marketing, clinical education and distribution infrastructure worldwide, support our ongoing technology developments and broaden Reliant’s role as a market leader.”
Reliant Technologies develops clinical solutions to repair and rejuvenate aging and environmentally damaged skin. Reliant is dedicated to providing the most advanced research, engineering and products to the global aesthetic marketplace. The company pioneered the development of fractional laser resurfacing which relies on novel high speed scanning systems and the Intelligent Optical Tracking� system to produce safe and effective results with minimal recovery time. The Fraxel family of products has quickly become the industry standard for aesthetic laser skin treatment. Because of their gentle, non-invasive approach to skin resurfacing, Fraxel lasers are used primarily by aesthetic physicians to treat periorbital wrinkles, pigmented lesions, acne scars and surgical scars. Fraxel lasers have received multiple FDA clearances and have been found safe and effective in treating all skin types and all areas of the face and body. Reliant is headquartered in Mountain View, California.
For more information, please visit: www.reliant-tech.com